Neurosense Therapeutics shares owned by Warberg Asset Management
Quarter-by-quarter ownership of Neurosense Therapeutics (NRSNW) shares owned by Warberg Asset Management
from 13F filings
Historical chart of Warberg Asset Management investment in Neurosense Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Neurosense Therapeutics held by Warberg Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurosense Therapeutics by Warberg Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $17k | 41k | 0.42 |
| 2023-12-31 | $5.0k | 64k | 0.08 |
| 2023-09-30 | $11k | 76k | 0.15 |
| 2023-06-30 | $15k | 78k | 0.20 |
| 2023-03-31 | $30k | 78k | 0.39 |
| 2022-12-31 | $14k | 80k | 0.18 |
| 2022-09-30 | $19k | 82k | 0.23 |
| 2022-06-30 | $39k | 77k | 0.51 |
| 2022-03-31 | $14k | 24k | 0.58 |
| 2021-12-31 | $61k | 67k | 0.92 |
Top funds holding Neurosense Therapeutics
View all funds holding Neurosense Therapeutics